Skip to main content

Roll out of the COVID:19 vaccine programme


This inquiry follows on from our February 2021 report on the development and rollout of the first vaccines in the UK

The Committee will question senior officials at DHSC, NHS England and the UK Health Security Agency on how well placed the government is to meet its full objectives for the COVID-19 vaccine programme, including:

  • progress with the COVID-19 vaccines programme since the NAO last reported in December 2020;
  • the drivers of success in the first phases of the mass roll-out: the rollout of first and second doses to all priority groups and all adults, and the rollout of first doses to 12-17 year olds
  • the future aims and challenges for the vaccines programme as the first phases of roll-out come to an end; and
  • the risks to sustainability and delivering value for money in future, including in phases yet to be evaluated such as the rollout of boosters, second doses for 12-17 year olds, and vaccines for younger children

If you have evidence on these issues please submit it here by Monday 21 March 2022.

This inquiry is no longer accepting evidence

The deadline for submissions was Monday 21 March 2022.

Upcoming events

View all events

No upcoming events scheduled

Contact us

  • Email:
  • Phone: 020 7219 5776 (General enquiries). For all media enquiries please contact Jessica Bridges Palmer / 07917488489
  • Address: Public Accounts Committee, House of Commons, London, SW1A 0AA